Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia

Journal of Clinical Psychiatry

Volumn 69, Issue 1, 2008, Pages 74-80

  Hudson, Teresa J ^a,b,c   Owen, Richard R ^a,c   Thrush, Carol R ^a,c   Armitage, Tracey L ^a,c,f   Thapa, Purushottam ^c,d,e  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b Research Education and Clinical Center (MIRECC)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e Arkansas State Hospital   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGE DISTRIBUTION; AKATHISIA; ARTICLE; CONTROLLED STUDY; DATA COLLECTION METHOD; DEMOGRAPHY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT COMPLIANCE; PHYSICIAN; POSITIVE AND NEGATIVE SYNDROME SCALE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM; SELF REPORT; STATISTICAL SIGNIFICANCE; SUBSTANCE ABUSE; VETERAN;

EID: 39549094662     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0110     Document Type: Article

References (34)

1. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Schizophrenia. Arlington, Va: American Psychiatric Association; 2004
2. Lehman AF, Kreyenbuhl J, Buchanan RW, et al. The schizophrenia patient outcomes research team (PORT): updated treatment recommendations 2003. Schizophr Bull 2004;30:193-217
3. Kane JM, Leucht S, Carpenter D, et al. The Expert Consensus Guideline Series. Optimizing pharmacologic treatment of psychotic disorders: introduction: methods, commentary, and summary. J Clin Psychiatry 2003;64(suppl 12):5-19
4. Management of Psychoses. Washington, DC: VA/DoD Evidence-Based Clinical Practice Guideline Working Group, Veterans Health Administration, Department of Veterans Affairs, and Health Affairs, Department of Defense, May 2004. Office of Quality and Performance publication 10Q-CPG/PSY-04. Available at: http://www.oqp.med.va.gov/cpg/cpg.htm. Accessibility confirmed July 27, 2007
5. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997;23:637-651
6. Lacro JP, Dunn LB, Dolder CR, et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002;63:892-909
7. Worrel JA, Marken PA, Beckman SE, et al. Atypical antipsychotic agents: a critical review. Am J Health Syst Pharm 2000;57:238-255
8. Perkins DO. Adherence to antipsychotic medications. J Clin Psychiatry 1999;60(suppl 21):25-30
9. Sullivan G, Wells KB, Morgenstern H, et al. Identifying modifiable risk factors for rehospitalization: a case-control study of seriously mentally ill persons in Mississippi. Am J Psychiatry 1995;152:1749-1756
10. Dolder CR, Lacro JP, Dunn LB, et al. Antipsychotic medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry 2002;159:103-108
11. Olfson M, Shea S, Feder A, et al. Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice. Arch Fam Med 2000:9:876-883
12. Leslie DL, Rosenheck RA. From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications. Am J Psychiatry 2002;159:1534-1540
13. Zygmunt A, Olfson M, Boyer CA, et al. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry 2002;159:1653-1664
14. Boczkowski JA, Zeichner A, DeSanto N. Neuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome report. J Consult Clin Psychol 1985;53:666-671
15. Sackett DL, Gibson ES, Taylor DW, et al. Randomized clinical trial of strategies for improving medication compliance in primary hypertension. Lancet 1975;1:1205-1207
16. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002;288:2868-2879
17. Mental Health Strategic Health Care Group, The Psychosis Working Group, Office of Performance and Quality: Veterans Health Administration clinical guideline for management of persons with psychoses. Washington, DC: Department of Veterans Affairs; 1997
18. Owen RR, Thrush CR, Kirchner JE, et al. Performance measurement for schizophrenia: adherence to guidelines for antipsychotic dose. Int J Qual Health Care 2000;12:475-482
19. Williams DK, Thrush CR, Armitage TL, et al. The effect of guideline implementation strategies on akathisia outcomes in schizophrenia. J Applied Res 2003;3:470-482
20. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276
21. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry 1989;154:672-676
22. Cuffel BJ, Fischer EP, Owen RR Jr, et al. An instrument for measurement of outcomes of care for schizophrenia: issues in development and implementation. Eval Health Prof 1997;20:96-108
23. Fischer EP, Cuffel BJ, Owen RR, et al. Schizophrenia Outcomes Module User's Manual. Little Rock, Ark: University of Arkansas for Medical Sciences; 1996
24. Miklowitz DJ, Goldstein MJ, Nuechterlein KH, et al. Expressed emotion, affective style, lithium compliance, and relapse in recent onset mania. Psychopharmacol Bull 1986;22:628-632
25. Miklowitz DJ, Goldstein MJ, Nuechterlein KH, et al. Family factors and the course of bipolar affective disorder. Arch Gen Psychiatry 1988;45:225-231
26. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA 1984;252:1905-1907
27. Ware JJ, Sherbourne CD. The MOS 36-item short-form health survey (SF-36), 1: conceptual framework and item selection. Medical Care 1992;30:473-483
28. Epstein LH, Cluss PA. A behavioral medicine perspective on adherence to long-term medical regimens. J Consult Clin Psychol 1982;50:950-971
29. Owen RR, Fischer EP, Booth BM, et al. Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr Serv 1996;47:853-858
30. Owen RR, Feng W, Thrush CR, et al. Variations in prescribing practices for novel antipsychotic medications among Veterans Affairs hospitals. Psychiatr Serv 2001;52:1523-1525
31. Fortney JC, Booth BM, Smith GR. Variation among VA hospitals in length of stay for treatment of depression. Psychiatr Serv 1996;47:608-613
32. Baicker K, Chandra A, Skinner JS, et al. Who you are and where you live: how race and geography affect the treatment of medicare beneficiaries. Health Aff 2004;Suppl Web Exclusives VAR33-44
33. Evans L, Spelman M. The problem of non-compliance with drug therapy. Drugs 1983;25:63-76
34. Waterhouse DM, Calzone KA, Mele C, et al. Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol 1993;11:1189-1197